Study S000285

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02403284
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 97
Start: 2013-03
Primary completion: 2021-04-28
Lead sponsor: Phoenix VA Health Care System
Conditions: Insulin Resistance
Interventions: DRUG:Liraglutide; DRUG:Sugar Pill
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:1593855

Registered primary outcomes

Whole Body Insulin Sensitivity (insulin suppression test) [3 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.